Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Compounded GLP-1 Guidepricing database · evidence ledger

Authors & reviewers

Dr. Parmis Mojarab

Editorial Auditor

Provisional profile. This profile is intentionally set to noindex until underlying credentials are independently verified. Only confirmed role information is shown.

Dr. Parmis Mojarab serves as Editorial Auditor. This profile lists only confirmed role information. Additional credential, license, institution, and specialty details are not published here pending independent verification, and no clinical-review authority or medical credential is asserted for this role.

The Editorial Auditor reviews published pages for adherence to our editorial standards, evidence policy, and disclosure requirements. This is an editorial-governance function and is distinct from medical review, which is performed by our named medical reviewer and lead clinical reviewer.

Credentials & verification

Dr. Parmis Mojarab — role and verification
RoleEditorial Auditor
Review scopeEditorial-governance review: adherence to editorial standards, evidence policy, and disclosure requirements. This is distinct from medical review.
VerificationCredential, license, institution, and specialty details are not published pending independent verification. No medical credential or clinical-review authority is asserted for this role.

What this reviewer signs

The Editorial Auditor reviews published pages for adherence to editorial standards, evidence policy, and disclosure requirements. This governance role is distinct from medical review and is not shown as any page's medical reviewer.

← All authors & reviewers · Publisher: US Peptides Partners LLC. This profile lists only confirmed information; nothing beyond the verified facts above is asserted. See the About page for ownership and the corrections route.